Premium
Indian vaccine makers took centre stage in 2020 as the country and emerging markets pinned their hopes on them to deliver millions of efficacious and affordable doses to treat Covid-19 that has plagued the world and caused more than a million deaths this year. The pharmaceutical sector in general also received ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
